Effect of mobile platform in improving compliance and efficacy of subcutaneous immunotherapy in children with allergic rhinitis

Abstract

Objective:To explore effect of mobile platform in improving compliance and efficacy of subcutaneous immunotherapy（SCIT） in children with allergic rhinitis（AR）. Method:From January to June 2018, 86 children diagnosed with AR and receiving SCIT were selected as research objects. According to the random sequence generated by the computer, the research objects were randomly assigned to the experimental group and the control group, with 43 cases in each group. The control group received conventional SCIT management, while the experimental group received mobile platform SCIT management relying on smart phones and computers. The SCIT shedding rate at the initial stage and the time taken to reach the maintenance period were compared between the two groups, as well as the visual simulation scale of rhinitis symptoms, four-point score and rhinoconjunctivia-related quality of life scores before and at the 6th month after the intervention. Result:There was no statistically significant difference in the initial SCIT shedding rate between the two groups（P>0.05）, and the average duration of the maintenance period of the experimental group was shorter than that of the control group, with statistically significant difference（P<0.05）. At the 6th month after intervention, there was no statistically significant difference in the scores of rhinitis symptoms by the four-point method between the two groups（P>0.05）, and there were statistically significant differences in the visual simulation scale of rhinitis symptoms and the scores of children's rhinoconjunctivia-related quality of life（P<0.05）. Conclusion:This study confirmed that the application of a mobile platform is of great significance for improving compliance and the treatment effects of SCIT in children with AR.